Charm Care (TSE:6062) Stock Profit Gains Clash With Revenue Dip

Charm Care stock came into this earnings print on a steady upward run, with single digit gains over the past week, month and quarter. Yet the real story sits deeper in the numbers. The market is reacting to a healthcare operator that now earns a trailing net margin of 8.2% and trades on a P/E of 11.9x, below both the wider Japanese healthcare industry and close peers. The headline is simple: solid profitability and relatively modest valuation now have to be weighed against a discounted cash flow value that sits well below the current ¥1,472 share price.

Love Charm Care’s current 8.2% net margin raises the question of whether its 11.9x P/E is really a bargain at ¥1,472. Take a look at our hand picked 18 high quality undervalued stocks for comparison.

FY 2026 Earnings Summary

• Revenue (Q4 FY 2026 vs Q4 FY 2025): ¥15,186m vs. ¥16,360m (change not specified in percentage terms)
• Net Income (Excl. Extra Items) (Q4 FY 2026 vs Q4 FY 2025): ¥1,487m vs. ¥1,094m (change not specified in percentage terms)
• Basic EPS (Q4 FY 2026 vs Q4 FY 2025): ¥45.50 vs. ¥33.49 (change not specified in percentage terms)
• Net Margin (Trailing 12 Months vs Prior Year): 8.2% vs. 6.3% (indicating improved profitability)

Prefer clean visuals instead of another wall of earnings tables and footnotes? See Charm Care’s full financial picture, including an at a glance valuation view, in our company report for Charm Care.

Charm Care earnings support a firmer profit story

Charm Care’s latest quarter backs the idea of a relatively resilient care operator. Net income excluding extra items is ¥1,487m compared with ¥1,094m a year earlier. Basic EPS moves from ¥33.49 to ¥45.50. The trailing net margin sits at 8.2% compared with 6.3% previously, which fits a narrative of improving profitability in a scale driven, operationally complex sector. For investors who see the company as a steady way to tap Japan’s aging demographics, these earnings lean in favour of that view.

Revenue softness keeps the cautious Charm Care view alive

The cautious side of the Charm Care story still has support. Q4 revenue is ¥15,186m compared with ¥16,360m in the prior year quarter, which raises fair questions about top line momentum in a sector often viewed as structurally supported. The stronger net income and higher net margin suggest tighter cost control, yet that only partly offsets concerns if revenue sits under pressure. For investors focusing on long term facility demand and occupancy, these mixed signals justify keeping execution and volume trends firmly in focus.

Compare Charm Care’s firmer margins and EPS with how the market priced the stock at ¥1,472 after this earnings release. Then see whether analysts think that balance of progress and revenue concern supports further upside or limits the story. See the consensus price target analysis for Charm Care

Take Control Of Your Next Move

If Charm Care’s mix of firmer margins, softer revenue and a modest P/E has your attention, register for free with Simply Wall St and add it to your Watchlist to keep an eye on price versus fair value and wait for a setup that fits your plan. Once you are invested, use the Portfolio Command Center to focus on essentials like earnings, valuation shifts and risk updates without getting buried in day to day noise. Round out your process with insights from thousands of investors through the Community so you can see how others are interpreting the same figures. This way you give yourself a better shot at spotting hidden catalysts or risks early and staying a step ahead of the market.

Seeking Alternatives Beyond Charm Care?

Fresh ideas often move first when momentum builds and breakout stories are still under the radar. Review these hand picked stock sets before the broader market focuses on them.

• Spot companies with strong balance sheets and steady fundamentals before they gain wider attention by reviewing the curated list of solid balance sheet and fundamentals stocks (40 results).
• Identify dividend momentum from businesses already paying distributions, then review the yield and payout profile using our focused 43 dividend fortresses.
• Follow developments in robotics and automation spending by concentrating on curated operators inside the 36 robotics and automation stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com